- Home
- COSM vs AIMD Comparison
COSM vs AIMD Comparison
Compare COSM & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COSM
- AIMD
- Stock Information
- Founded
- COSM 2009
- AIMD 1984
- Country
- COSM Greece
- AIMD United States
- Employees
- COSM N/A
- AIMD N/A
- Industry
- COSM Other Pharmaceuticals
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- COSM Health Care
- AIMD Health Care
- Exchange
- COSM Nasdaq
- AIMD Nasdaq
- Market Cap
- COSM 8.2M
- AIMD 8.2M
- IPO Year
- COSM 2013
- AIMD N/A
- Fundamental
- Price
- COSM $0.45
- AIMD $0.54
- Analyst Decision
- COSM
- AIMD
- Analyst Count
- COSM 0
- AIMD 0
- Target Price
- COSM N/A
- AIMD N/A
- AVG Volume (30 Days)
- COSM 814.2K
- AIMD 168.9K
- Earning Date
- COSM 05-15-2025
- AIMD 05-12-2025
- Dividend Yield
- COSM N/A
- AIMD N/A
- EPS Growth
- COSM N/A
- AIMD N/A
- EPS
- COSM N/A
- AIMD N/A
- Revenue
- COSM $54,426,402.00
- AIMD $20,729.00
- Revenue This Year
- COSM $28.14
- AIMD N/A
- Revenue Next Year
- COSM N/A
- AIMD N/A
- P/E Ratio
- COSM N/A
- AIMD N/A
- Revenue Growth
- COSM 1.97
- AIMD N/A
- 52 Week Low
- COSM $0.28
- AIMD $0.40
- 52 Week High
- COSM $1.58
- AIMD $1.46
- Technical
- Relative Strength Index (RSI)
- COSM 53.31
- AIMD 50.95
- Support Level
- COSM $0.40
- AIMD $0.51
- Resistance Level
- COSM $0.50
- AIMD $0.57
- Average True Range (ATR)
- COSM 0.06
- AIMD 0.04
- MACD
- COSM 0.01
- AIMD -0.00
- Stochastic Oscillator
- COSM 46.91
- AIMD 36.71
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.